From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Geminii, Inc., a company developing bioelectronic medicines, today announced that it will present new data at the AACR Annual Meeting 2026 in San Diego highlighting its non-small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results